Michael A. Levy

6.0k total citations
46 papers, 907 citations indexed

About

Michael A. Levy is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Michael A. Levy has authored 46 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Genetics and 10 papers in Genetics. Recurrent topics in Michael A. Levy's work include Epigenetics and DNA Methylation (10 papers), Genetics and Neurodevelopmental Disorders (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Michael A. Levy is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Genetics and Neurodevelopmental Disorders (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Michael A. Levy collaborates with scholars based in Canada, United States and Japan. Michael A. Levy's co-authors include Mark Lubell, Nathalie G. Bérubé, N. McRoberts, Yan Jiang, Bekim Sadiković, Amanda A. Gaskin, Adam J. Birkenheuer, Frank Steurer, Barbara C. Hegarty and Marina Gramiccia and has published in prestigious journals such as Nature, Journal of Neuroscience and Blood.

In The Last Decade

Michael A. Levy

39 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Levy Canada 18 295 196 186 142 67 46 907
Herawati Sudoyo Indonesia 27 641 2.2× 255 1.3× 785 4.2× 139 1.0× 43 0.6× 100 2.1k
Elizeu Fagundes de Carvalho Brazil 17 446 1.5× 96 0.5× 535 2.9× 144 1.0× 13 0.2× 104 1.1k
Amha Gebremedhin Ethiopia 15 217 0.7× 195 1.0× 742 4.0× 38 0.3× 35 0.5× 36 1.3k
Shazia Mahamdallie United Kingdom 13 360 1.2× 149 0.8× 347 1.9× 57 0.4× 31 0.5× 17 800
Max Shpak United States 16 210 0.7× 57 0.3× 306 1.6× 30 0.2× 38 0.6× 41 697
Isabelle Bolon Switzerland 20 205 0.7× 117 0.6× 413 2.2× 87 0.6× 8 0.1× 48 1.1k
Jaime E. Bernal Colombia 21 194 0.7× 33 0.2× 228 1.2× 67 0.5× 33 0.5× 95 1.1k
Elizabeth Willott United States 17 634 2.1× 168 0.9× 93 0.5× 15 0.1× 43 0.6× 23 1.3k
William Byrd United States 16 822 2.8× 192 1.0× 244 1.3× 55 0.4× 94 1.4× 58 2.0k
Akira Nishikawa Japan 21 520 1.8× 78 0.4× 153 0.8× 186 1.3× 70 1.0× 57 1.4k

Countries citing papers authored by Michael A. Levy

Since Specialization
Citations

This map shows the geographic impact of Michael A. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Levy more than expected).

Fields of papers citing papers by Michael A. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Levy. The network helps show where Michael A. Levy may publish in the future.

Co-authorship network of co-authors of Michael A. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Levy. A scholar is included among the top collaborators of Michael A. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Levy. Michael A. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haghshenas, Sadegheh, Michael A. Levy, Raissa Relator, et al.. (2025). Identification of an episignature for the MEF2C-associated syndrome. European Journal of Human Genetics. 34(1). 53–60.
2.
Campbell, Christopher, Leigh Demain, Sarah Jenkinson, et al.. (2025). Evaluating DNA methylation episignatures as a first-tier diagnostic test in individuals with suspected genetic disorders. European Journal of Human Genetics. 34(2). 296–299.
3.
Relator, Raissa, Michael A. Levy, Ankit Verma, et al.. (2025). Identification of genetic and non-genetic modifiers of genomic imprinting through screening of imprinted DMR methylation in humans. Epigenetics & Chromatin. 18(1). 47–47.
4.
Relator, Raissa, Irene Valenzuela, Adri N. Mul, et al.. (2025). Discovery of a DNA methylation episignature as a molecular biomarker for fetal alcohol syndrome. Genetics in Medicine. 27(12). 101586–101586.
5.
Malicki, Denise, et al.. (2023). Unusual pattern of metastatic disease in a patient in their early childhood with group 4 medulloblastoma. BMJ Case Reports. 16(5). e253877–e253877. 1 indexed citations
6.
Haghshenas, Sadegheh, Aidin Foroutan, Michael A. Levy, et al.. (2023). Identification of a DNA methylation signature for Renpenning syndrome (RENS1), a spliceopathy. European Journal of Human Genetics. 31(8). 879–886. 2 indexed citations
7.
Chin‐Yee, Benjamin, Ian Cheong, Michael A. Levy, et al.. (2022). Mutational Landscape of Patients Referred for Elevated Hemoglobin Level. Current Oncology. 29(10). 7209–7217.
8.
Hsia, Cyrus C., Laila C. Schenkel, Benjamin D. Hedley, et al.. (2022). Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies. Molecular Diagnosis & Therapy. 26(3). 333–343. 8 indexed citations
9.
Chin‐Yee, Benjamin, Ian Cheong, Cyrus C. Hsia, et al.. (2022). A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) Study. Journal of General Internal Medicine. 38(8). 1828–1833. 6 indexed citations
10.
Feng, Biao, Saumik Biswas, Michael A. Levy, et al.. (2022). ANRIL regulates multiple molecules of pathogenetic significance in diabetic nephropathy. PLoS ONE. 17(8). e0270287–e0270287. 9 indexed citations
11.
Kawata, Eri, Benjamin D. Hedley, Benjamin Chin‐Yee, et al.. (2021). Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?. International Journal of Laboratory Hematology. 44(2). 333–341. 2 indexed citations
12.
Rooney, Kathleen, Michael A. Levy, Sadegheh Haghshenas, et al.. (2021). Identification of a DNA Methylation Episignature in the 22q11.2 Deletion Syndrome. International Journal of Molecular Sciences. 22(16). 8611–8611. 13 indexed citations
13.
Haghshenas, Sadegheh, Michael A. Levy, Jennifer Kerkhof, et al.. (2021). Detection of a DNA Methylation Signature for the Intellectual Developmental Disorder, X-Linked, Syndromic, Armfield Type. International Journal of Molecular Sciences. 22(3). 1111–1111. 6 indexed citations
14.
Schenkel, Laila C., Erfan Aref‐Eshghi, Kathleen Rooney, et al.. (2021). DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome. Clinical Epigenetics. 13(1). 2–2. 21 indexed citations
15.
Kawata, Eri, Alejandro Lazo‐Langner, Anargyros Xenocostas, et al.. (2020). Clinical value of next‐generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome. British Journal of Haematology. 192(4). 729–736. 8 indexed citations
16.
Seah, Claudia, Michael A. Levy, Yan Jiang, et al.. (2008). Neuronal Death Resulting from Targeted Disruption of the Snf2 Protein ATRX Is Mediated by p53. Journal of Neuroscience. 28(47). 12570–12580. 53 indexed citations
17.
Levy, Michael A., Andrew D. Fernandes, Deanna C. Tremblay, Claudia Seah, & Nathalie G. Bérubé. (2008). The SWI/SNF protein ATRX co-regulates pseudoautosomal genes that have translocated to autosomes in the mouse genome. BMC Genomics. 9(1). 468–468. 19 indexed citations
18.
Gaskin, Amanda A., Peter M. Schantz, Joan E. Jackson, et al.. (2002). Visceral Leishmaniasis in a New York Foxhound Kennel. Journal of Veterinary Internal Medicine. 16(1). 34–34. 110 indexed citations
19.
Verlinsky, Yury, Svetlana Rechitsky, Oleg Verlinsky, et al.. (2002). Preimplantation diagnosis for neurofibromatosis. Reproductive BioMedicine Online. 4(3). 218–222. 39 indexed citations
20.
Brüls, Thomas, Gàbor Gyapay, Jean‐Louis Petit, et al.. (2001). A physical map of human chromosome 14. Nature. 409(6822). 947–948. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herawati Sudoyo Breakdown of academic impact, for papers by Elizeu Fagundes de Carvalho Breakdown of academic impact, for papers by Amha Gebremedhin Breakdown of academic impact, for papers by Shazia Mahamdallie Breakdown of academic impact, for papers by Max Shpak Breakdown of academic impact, for papers by Isabelle Bolon Breakdown of academic impact, for papers by Jaime E. Bernal Breakdown of academic impact, for papers by Elizabeth Willott Breakdown of academic impact, for papers by William Byrd Breakdown of academic impact, for papers by Akira Nishikawa
Rankless by CCL
2026